Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Serum cytokine levels differ according to major cardiovascular risk factors in patients with lower limb atherosclerosis.

Jalkanen J, Hollmén M, Maksimow M, Jalkanen S, Hakovirta H.

Cytokine. 2019 Feb;114:74-80. doi: 10.1016/j.cyto.2018.11.001. Epub 2018 Nov 13.

PMID:
30442459
2.

Correlation between increasing tissue ischemia and circulating levels of angiogenic growth factors in peripheral artery disease.

Jalkanen J, Hautero O, Maksimow M, Jalkanen S, Hakovirta H.

Cytokine. 2018 Oct;110:24-28. doi: 10.1016/j.cyto.2018.04.012. Epub 2018 Apr 23.

PMID:
29689451
3.

Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial.

Bellingan G, Brealey D, Mancebo J, Mercat A, Patroniti N, Pettilä V, Quintel M, Vincent JL, Maksimow M, Jalkanen M, Piippo I, Ranieri VM.

Trials. 2017 Nov 13;18(1):536. doi: 10.1186/s13063-017-2234-7.

4.

Plasma levels of hepatocyte growth factor and placental growth factor predict mortality in a general population: a prospective cohort study.

Santalahti K, Havulinna A, Maksimow M, Zeller T, Blankenberg S, Vehtari A, Joensuu H, Jalkanen S, Salomaa V, Salmi M.

J Intern Med. 2017 Oct;282(4):340-352. doi: 10.1111/joim.12648. Epub 2017 Jul 31.

5.

Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.

Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, Kähönen M, Lyytikäinen LP, Raitoharju E, Seppälä I, Sarin AP, Ripatti S, Palotie A, Perola M, Viikari JS, Jalkanen S, Maksimow M, Salomaa V, Salmi M, Kettunen J, Raitakari OT.

Am J Hum Genet. 2017 Jan 5;100(1):40-50. doi: 10.1016/j.ajhg.2016.11.007. Epub 2016 Dec 15.

6.

Cerebrospinal fluid cytokines in Lyme neuroborreliosis.

Pietikäinen A, Maksimow M, Kauko T, Hurme S, Salmi M, Hytönen J.

J Neuroinflammation. 2016 Oct 18;13(1):273.

7.

Soluble CD73 in Critically Ill Septic Patients - Data from the Prospective FINNAKI Study.

Vaara ST, Hollmén M, Korhonen AM, Maksimow M, Ala-Kokko T, Salmi M, Jalkanen S, Pettilä V; FINNAKI Study Group.

PLoS One. 2016 Oct 12;11(10):e0164420. doi: 10.1371/journal.pone.0164420. eCollection 2016.

8.

Cytokine profile and maternal depression and anxiety symptoms in mid-pregnancy-the FinnBrain Birth Cohort Study.

Karlsson L, Nousiainen N, Scheinin NM, Maksimow M, Salmi M, Lehto SM, Tolvanen M, Lukkarinen H, Karlsson H.

Arch Womens Ment Health. 2017 Feb;20(1):39-48. doi: 10.1007/s00737-016-0672-y. Epub 2016 Oct 4.

PMID:
27699637
9.

Compared to Intermittant Claudication Critical Limb Ischemia Is Associated with Elevated Levels of Cytokines.

Jalkanen J, Maksimow M, Hollmén M, Jalkanen S, Hakovirta H.

PLoS One. 2016 Sep 9;11(9):e0162353. doi: 10.1371/journal.pone.0162353. eCollection 2016.

10.

Circulating Cytokines Predict the Development of Insulin Resistance in a Prospective Finnish Population Cohort.

Santalahti K, Maksimow M, Airola A, Pahikkala T, Hutri-Kähönen N, Jalkanen S, Raitakari OT, Salmi M.

J Clin Endocrinol Metab. 2016 Sep;101(9):3361-9. doi: 10.1210/jc.2016-2081. Epub 2016 Jun 30.

PMID:
27362289
11.

G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer.

Hollmén M, Karaman S, Schwager S, Lisibach A, Christiansen AJ, Maksimow M, Varga Z, Jalkanen S, Detmar M.

Oncoimmunology. 2015 Nov 24;5(3):e1115177. eCollection 2016 Mar.

12.

The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection.

Ritchie SC, Würtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, Sarin AP, Kangas AJ, Soininen P, Aalto K, Seppälä I, Raitoharju E, Salmi M, Maksimow M, Männistö S, Kähönen M, Juonala M, Ripatti S, Lehtimäki T, Jalkanen S, Perola M, Raitakari O, Salomaa V, Ala-Korpela M, Kettunen J, Inouye M.

Cell Syst. 2015 Oct 28;1(4):293-301. doi: 10.1016/j.cels.2015.09.007. Epub 2015 Oct 22.

13.

Hypoxia-induced inflammation and purinergic signaling in cross clamping the human aorta.

Jalkanen J, Maksimow M, Jalkanen S, Hakovirta H.

Springerplus. 2016 Jan 4;5:2. doi: 10.1186/s40064-015-1651-x. eCollection 2016.

14.

Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate.

Elovaara H, Huusko T, Maksimow M, Elima K, Yegutkin GG, Skurnik M, Dobrindt U, Siitonen A, McPherson MJ, Salmi M, Jalkanen S.

PLoS One. 2015 Nov 10;10(11):e0142367. doi: 10.1371/journal.pone.0142367. eCollection 2015.

15.

The authors reply.

Maksimow M, Kyhälä L, Kylänpää L, Mentula P, Yegutkin GG, Repo H, Salmi M.

Crit Care Med. 2015 Jul;43(7):e260. doi: 10.1097/CCM.0000000000000977. No abstract available.

PMID:
26079243
16.

Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs.

Yegutkin GG, Auvinen K, Karikoski M, Rantakari P, Gerke H, Elima K, Maksimow M, Quintero IB, Vihko P, Salmi M, Jalkanen S.

Mediators Inflamm. 2014;2014:485743. doi: 10.1155/2014/485743. Epub 2014 Aug 24.

17.

Postnatal development and LPS responsiveness of pulmonary adenosine receptor expression and of adenosine-metabolizing enzymes in mice.

Metsola J, Maksimow M, Ojaniemi M, Metsola H, Marttila-Ichihara F, Vuolteenaho R, Yegutkin GG, Salmi M, Hallman M, Jalkanen S.

Pediatr Res. 2014 Dec;76(6):515-21. doi: 10.1038/pr.2014.132. Epub 2014 Sep 4.

PMID:
25188742
18.

Early prediction of persistent organ failure by soluble CD73 in patients with acute pancreatitis*.

Maksimow M, Kyhälä L, Nieminen A, Kylänpää L, Aalto K, Elima K, Mentula P, Lehti M, Puolakkainen P, Yegutkin GG, Jalkanen S, Repo H, Salmi M.

Crit Care Med. 2014 Dec;42(12):2556-64. doi: 10.1097/CCM.0000000000000550.

PMID:
25126879
19.

Distribution and medical impact of loss-of-function variants in the Finnish founder population.

Lim ET, Würtz P, Havulinna AS, Palta P, Tukiainen T, Rehnström K, Esko T, Mägi R, Inouye M, Lappalainen T, Chan Y, Salem RM, Lek M, Flannick J, Sim X, Manning A, Ladenvall C, Bumpstead S, Hämäläinen E, Aalto K, Maksimow M, Salmi M, Blankenberg S, Ardissino D, Shah S, Horne B, McPherson R, Hovingh GK, Reilly MP, Watkins H, Goel A, Farrall M, Girelli D, Reiner AP, Stitziel NO, Kathiresan S, Gabriel S, Barrett JC, Lehtimäki T, Laakso M, Groop L, Kaprio J, Perola M, McCarthy MI, Boehnke M, Altshuler DM, Lindgren CM, Hirschhorn JN, Metspalu A, Freimer NB, Zeller T, Jalkanen S, Koskinen S, Raitakari O, Durbin R, MacArthur DG, Salomaa V, Ripatti S, Daly MJ, Palotie A; Sequencing Initiative Suomi (SISu) Project.

PLoS Genet. 2014 Jul 31;10(7):e1004494. doi: 10.1371/journal.pgen.1004494. eCollection 2014 Jul.

20.

Circulating cytokines in predicting development of severe acute pancreatitis.

Nieminen A, Maksimow M, Mentula P, Kyhälä L, Kylänpää L, Puolakkainen P, Kemppainen E, Repo H, Salmi M.

Crit Care. 2014 May 21;18(3):R104. doi: 10.1186/cc13885.

21.

Use of interferon beta for acute respiratory distress syndrome: proceed with caution--authors' reply.

Bellingan G, Montgomery H, Maksimow M, Salmi M, Jalkanen S.

Lancet Respir Med. 2014 Apr;2(4):e2-3. doi: 10.1016/S2213-2600(14)70052-9. No abstract available.

PMID:
24717630
22.

The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.

Bellingan G, Maksimow M, Howell DC, Stotz M, Beale R, Beatty M, Walsh T, Binning A, Davidson A, Kuper M, Shah S, Cooper J, Waris M, Yegutkin GG, Jalkanen J, Salmi M, Piippo I, Jalkanen M, Montgomery H, Jalkanen S.

Lancet Respir Med. 2014 Feb;2(2):98-107. doi: 10.1016/S2213-2600(13)70259-5. Epub 2013 Dec 23.

PMID:
24503265
23.

Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations.

Aalto K, Maksimow M, Juonala M, Viikari J, Jula A, Kähönen M, Jalkanen S, Raitakari OT, Salmi M.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):523-32. doi: 10.1161/ATVBAHA.111.238030. Epub 2011 Nov 23.

PMID:
22116093
24.

Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer.

Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, Jalkanen S.

Blood. 2011 Sep 29;118(13):3725-33. doi: 10.1182/blood-2010-09-311076. Epub 2011 Aug 5.

25.

Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages.

Palani S, Maksimow M, Miiluniemi M, Auvinen K, Jalkanen S, Salmi M.

Eur J Immunol. 2011 Jul;41(7):2052-63. doi: 10.1002/eji.201041376. Epub 2011 Jun 1.

26.

Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes.

Hänninen A, Maksimow M, Alam C, Morgan DJ, Jalkanen S.

Eur J Immunol. 2011 Mar;41(3):634-44. doi: 10.1002/eji.201040760. Epub 2011 Feb 10.

27.

T cells expressing two different T cell receptors form a heterogeneous population containing autoreactive clones.

Kekäläinen E, Hänninen A, Maksimow M, Arstila TP.

Mol Immunol. 2010 Nov-Dec;48(1-3):211-8. doi: 10.1016/j.molimm.2010.08.008. Epub 2010 Sep 15.

PMID:
20828824
28.

Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation.

Karikoski M, Irjala H, Maksimow M, Miiluniemi M, Granfors K, Hernesniemi S, Elima K, Moldenhauer G, Schledzewski K, Kzhyshkowska J, Goerdt S, Salmi M, Jalkanen S.

Eur J Immunol. 2009 Dec;39(12):3477-87. doi: 10.1002/eji.200939896.

29.

Incomplete Killing And Enhanced Activation of Islet-Reactive CD8+ T Cells by FasL-Expressing Dendritic Cells Limits Protection from Diabetes.

Maksimow M, Alam C, Hänninen A.

Rev Diabet Stud. 2008 Fall;5(3):144-53. doi: 10.1900/RDS.2008.5.144. Epub 2008 Nov 10.

30.

Macrophage mannose receptor on lymphatics controls cell trafficking.

Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemelä J, Martinez-Pomares L, Salmi M, Jalkanen S.

Blood. 2008 Jul 1;112(1):64-72. doi: 10.1182/blood-2007-10-118984. Epub 2008 Apr 23.

PMID:
18434610
31.

Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets.

Hänninen A, Nurmela R, Maksimow M, Heino J, Jalkanen S, Kurts C.

Am J Pathol. 2007 Jan;170(1):240-50. Erratum in: Am J Pathol. 2008 Apr;172(4):1153.

32.

Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity.

Maksimow M, Miiluniemi M, Marttila-Ichihara F, Jalkanen S, Hänninen A.

Blood. 2006 Aug 15;108(4):1298-305. Epub 2006 Apr 18.

PMID:
16621963
33.

Fas costimulation of naive CD4 T cells is controlled by NF-kappaB signaling and caspase activity.

Maksimow M, Söderström TS, Jalkanen S, Eriksson JE, Hänninen A.

J Leukoc Biol. 2006 Feb;79(2):369-77. Epub 2005 Dec 5.

PMID:
16330535
34.

Monitoring promoter activity in a single bacterial cell by using green and red fluorescent proteins.

Hakkila K, Maksimow M, Rosengren A, Karp M, Virta M.

J Microbiol Methods. 2003 Jul;54(1):75-9.

PMID:
12732423
35.

Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cells is compensated by costimulation of surviving T cells.

Maksimow M, Santanen M, Jalkanen S, Hänninen A.

Blood. 2003 May 15;101(10):4022-8. Epub 2003 Jan 16.

PMID:
12531803
36.

Simultaneous detection of bacteria expressing GFP and DsRed genes with a flow cytometer.

Maksimow M, Hakkila K, Karp M, Virta M.

Cytometry. 2002 Apr 1;47(4):243-7.

PMID:
11933014
37.

Reporter genes lucFF, luxCDABE, gfp, and dsred have different characteristics in whole-cell bacterial sensors.

Hakkila K, Maksimow M, Karp M, Virta M.

Anal Biochem. 2002 Feb 15;301(2):235-42.

PMID:
11814294

Supplemental Content

Loading ...
Support Center